tm
Seeing Is Believing
tm
Seeing Is Believing
TALS is currently covered by 1 analysts with an average price target of $-3.9. This is a potential upside of $-6.62 (-243.38%) from yesterday's end of day stock price of $2.72.
Talaris Therapeutics's activity chart (see below) currently has 16 price targets and 11 ratings on display. The stock rating distribution of TALS is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 46.67% with an average time for these price targets to be met of 183 days.
Highest price target for TALS is $20, Lowest price target is $20.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 17-Apr-2023. First documented stock forecast 01-Jun-2021.
Currently out of the existing stock ratings of TALS, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$12
2 years ago
(17-Apr-2023)
2/3 (66.67%)
$-1.69 (-12.34%)
86
Hold
$6
$-19.69 (-76.64%)
$8
2 years 1 months 25 days ago
(23-Feb-2023)
2/5 (40%)
$-12.23 (-67.09%)
303
Hold
$7
$-18.69 (-72.75%)
$7
2 years 5 months 28 days ago
(20-Oct-2022)
1/3 (33.33%)
$-5.94 (-45.90%)
160
What is TALS (Talaris Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TALS (Talaris Therapeutics) with a proven track record?
Which analyst has the current lower performing score on TALS (Talaris Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TALS (Talaris Therapeutics)?
Which analyst is the currently most bullish on TALS (Talaris Therapeutics)?
Which analyst is the currently most reserved on TALS (Talaris Therapeutics)?
